Loop diuretics for patients with acute renal failure: Helpful or harmful?

JAMA

Volumn 288, Issue 20, 2002, Pages 2599-2601

  Lameire, Norbert ^a   Vanholder, Raymond ^a   Van Biesen, Wim ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; DOPAMINE; ETACRYNIC ACID; FUROSEMIDE; LOOP DIURETIC AGENT; MANNITOL; NITROFURAL;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; BOLUS INJECTION; CELL PROTECTION; CLINICAL FEATURE; CLINICAL TRIAL; CRITICAL ILLNESS; DISEASE COURSE; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; EDITORIAL; HEALTH CARE COST; HEARING IMPAIRMENT; HUMAN; HYDRATION; KIDNEY FUNCTION; MULTIPLE ORGAN FAILURE; OLIGURIA; OTOTOXICITY; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM;

EID: 0037184470     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.288.20.2599     Document Type: Editorial

References (26)

1. Liano F, Pascual J, for the Madrid Acute Renal Failure Study Group. Epidemiology of acute renal failure: A prospective, multicenter, community-based study. Kidney Int. 1996;50:811-818.
2. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT. Hospital-acquired renal insufficiency: A prospective study. Am J Med. 1983;74:243-248.
3. Brivet FG, Kleinknecht DJ, Loirat P, Landais PJ, for the French Study Group on Acute Renal Failure. Acute renal failure in intensive care units-causes, outcome, and prognostic factors of hospital mortality: A prospective, multicenter study. Crit Care Med. 1996;24:192-198.
4. Chertow GM, Lazarus JM, Paganini EP, Allgren RL, Lafayette RA, Sayegh MH, for The Auriculin Anaritide Acute Renal Failure Study Group. Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis. J Am Soc Nephrol. 1998;9:692-698.
5. Chertow GM, Christiansen CL, Cleary PD, Munro C, Lazarus JM. Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch Intern Med. 1995;155:1505-1511.
6. Liano F, Junco E, Pascual J, Madero R, Verde E, for the Madrid Acute Renal Failure Study Group. The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. Kidney Int Suppl. 1998;66:S16-S24.
7. Douma CE, Redekop WK, van der Meulen JH, et al. Predicting mortality in intensive care patients with acute renal failure treated with dialysis. J Am Soc Nephrol. 1997;8:111-117.
8. Spiegel D, Ulian M, Zerbe G, Berl T. Determinants of survival and recovery in acute renal failure patients dialyzed in intensive care unit. Am J Nephrol. 1991;11:44-47.
9. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality: A cohort analysis. JAMA. 1996;275:1489-1494.
10. Anderson RJ, Linas SL, Berns AS, et al. Nonoliguric acute renal failure. N Engl J Med. 1977;296:1134-1138.
11. Rahman SN, Conger JD. Glomerular and tubular factors in urine flow rates of acute renal failure patients. Am J Kidney Dis. 1994;23:788-793.
12. Better OS, Rubinstein I, Winaver JM, Knochel JP. Mannitol therapy revisited (1940-1997). Kidney Int. 1997;52:886-894.
13. Brezis M, Rosen S. Hypoxia of the renal medulla - Its implications for disease. N Engl J Med. 1995;332:647-655.
14. Brezis M, Agmon Y, Epstein FH. Determinants of intrarenal oxygenation, I: Effects of diuretics. Am J Physiol. 1994;267(6 Pt 2):F1059-F1062.
15. Majumdar S, Kjellstrand CM. Why do we use diuretics in acute renal failure? Semin Dial. 1996;9:454-459.
16. Kellum JA. Diuretics in acute renal failure: Protective or deleterious? Blood Purif. 1997;15:319-322.
17. Mehta RL, Pascual MT, Soroko S, Chertow GM, for the PICARD Study Group. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA. 2002;288:2547-2553.
18. Brown CD, Ogg CS, Cameron JS. High dose furosemide in acute renal failure: A controlled trial. Clin Nephrol. 1981;15:90-96.
19. Kleinknecht D, Ganeval D, Gonzalez-Duque LA, Fermaniau J. Furosemide in acute, oliguric renal failure: A controlled trial. Nephron. 1976;17:51-58.
20. Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml J, Hiesmayr M. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol. 2000;11:97-104.
21. Stevens MA, McCullough PA, Tobin KJ, et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy - Results of the PRINCE study. J Am Coll Cardiol. 1999;33:403-411.
22. Shilliday IR, Quinn KJ, Allison ME. Loop diuretics in the management of acute renal failure: A prospective, double-blind, placebo-controlled, randomized study. Nephrol Dial Transplant. 1997;12:2592-2596.
23. Dishart MK, Kellum JA. An evaluation of pharmacological strategies for the prevention and treatment of acute renal failure. Drugs. 2000;59:79-91.
24. Venkataram R, Kellum JA. The role of diuretic agents in the management of acute renal failure. Contrib Nephrol. 2001;132:158-170.
25. Sanders PW, Booker BB, Bishop JB, Cheung HC. Mechanisms of intranephronal proteinaceous cast formation by low molecular weight proteins. J Clin Invest. 1990;85:570-578.
26. Wigand ME, Heidland A. Ototoxic side-effects of high doses of furosemide in patients with uremia. Postgrad Med J. 1971;47(suppl):54-56.